Figure S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

Figure S5. Proportion of cells expression each of the 16 markers used for multiplex immunohistochemistry (mIHC) split by timepoint and fast vs slow progressor status.